US › Healthcare

The Cooper Companies, Inc (COO)

US · Healthcare · Medical Instruments & Supplies

$74.69+0.62%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$1.08B
Revenue YoY
+7.9%
Net profit
$-77.9M
Profit YoY
-188.8%
EPS
$1.21
EPS estimate
$1.09
Net margin
-7.2%

EPS came in at 1.21 against a street estimate of 1.09 — a beat of 11.0%.

Key statistics

Market cap
$13.71B
P/E
62.9
Forward P/E
14.7
P/B
1.71
Book value
$42.27
EPS (TTM)
$1.18
52-week high
$89.83
52-week low
$58.89
50-day MA
$68.05
200-day MA
$73.08
Beta
0.82

Analyst view

Analysts rate The Cooper Companies, Inc a buy (11 buy, 8 hold, 0 sell out of 19) with an average price target of $81.21.

Shareholding

Insiders
0.61%
Institutions
106.33%

Largest institutional holders

FundStake
Vanguard Group Inc12.07%
BlackRock Inc8.52%
Vanguard Capital Management, LLC6.52%
T. Rowe Price Investment Management,Inc.4.65%
State Street Corp4.50%
Vanguard Portfolio Management, LLC4.47%
Capital World Investors3.80%
Browning West LP3.58%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for The Cooper Companies, Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.